Project Grant R43AG082588

Award Date 9/25/24
Completion Date 8/31/25
Dollars Obligated $865K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Rhode Island, USA
Similar Awards
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) federal grant program, awarded Koronis Biomedical Technologies Corporation (KBT) a $1,010,368 project grant to develop and validate a novel interactive gaming platform that facilitates cognitive interventions for individuals living with mild cognitive impairment (MCI), Alzheimer's disease (AD), and other related dementias. The proposed system will provide a modular series of short, evidence-based cognitive training...
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, awarded a $811,228 Project Grant to B.A. Maze, Inc. on September 25, 2024. The grant will fund the development of the At-Home Health Station (AHS), a plug-and-play modular system designed to simplify digital experiences for individuals with cognitive impairment or Alzheimer's disease and related dementias. The AHS system aims to promote health function and independence through remote patient...
The National Institute on Aging (NIA) awarded a $499,996 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Beaver Health, Inc., a minority-owned, woman-owned small business, to develop a prototype of the COMPASS conversational AI assistant. COMPASS is designed to provide personalized, culturally responsive support and coordination for Alzheimer's disease and related dementia (ADRD) caregivers in real-time. The 12-month project aims to develop and test the initial...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $499,796 to Clear Session, Inc. to develop an innovative digital visualization tool to improve communication between clinicians, Latino Alzheimer's disease and related dementias (ADRD) patients, and their caregivers. The tool is designed to be linguistically and culturally tailored to break down complex medical information in a clear and comprehensible way, thereby enhancing healthcare...
This $1.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will support Memorywell, Inc. in delivering services under the Aging Research federal grant program (CFDA 93.866). Specifically, Memorywell will partner with the University of California San Francisco Acute Care for Elders unit to adapt its life story solution for use in acute care hospital settings, where brief patient life stories would be incorporated into electronic...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $349,333.00 to Rendever, Inc. to develop and test the feasibility of a new virtual reality (VR) platform tailored to support dementia caregivers. The VR-CARES initiative aims to create an immersive VR environment that enables caregivers to connect virtually, access support groups, receive training, and engage in shared experiences to alleviate feelings of loneliness and stress, and cultivate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $835,056 to Trustees of Tufts College (Tufts University) to develop a multi-modal system of wearable biosensors and associated machine learning algorithms for the continuous monitoring of mobility and cognitive function in an aging population. The key products and services to be delivered under this award include: 1) a system of flexible, breathable, and inconspicuous eutectogel sensor patches...
The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
This federal Project Grant award, valued at $441,612 and granted by the National Institute on Aging (CFDA 93.866 - Aging Research), supports research to investigate the relationship between modifiable risk factors and digital cognitive markers for early detection of cognitive decline associated with Alzheimer's disease. The project aims to leverage digital assessments, such as digital pen and voice recordings, in the Framingham Heart Study cohort to monitor cognitive changes in relation to...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Aster Labs, Inc. provides $499,758 to develop an automated system for detecting and reporting lapses in the performance of activities of daily living (ADLs) for individuals with Alzheimer's disease and related dementias. The ActivVerify system will leverage a discreet electronic shoe insole with sensors to automatically and accurately detect and identify ADLs, and then determine and verify...

This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $864,674 to Lifebio Inc. to develop a prototype for the LifeBioTalk platform. LifeBioTalk is a tablet-based system designed to provide stimulating audiovisual content narrated by a human-like avatar to engage people with Alzheimer's disease and related dementias. The goal is to reduce challenging behaviors and caregiver burden by promoting mental stimulation, enjoyment, and reducing loneliness for the person with dementia. In Phase I, Lifebio will design a prototype with six scripted 22-minute episodes and assess its acceptability, feasibility, and preliminary efficacy through a trial with 35 participant dyads (a person with dementia and their care partner). The long-term vision is for LifeBioTalk to use AI and machine learning to tailor content and detect user engagement based on facial imaging and other data. This award supports Lifebio's efforts to create innovative digital health technologies targeting the needs of aging populations, particularly those affected by Alzheimer's disease and related dementias.

Generated 7/15/25, 4:07 AM